Ginkgo biloba için Age-Related Cognitive Decline

Q: Does Ginkgo biloba help with Age-Related Cognitive Decline?

Based on 40 studies with 8,000 participants, there is limited but promising evidence that Ginkgo biloba may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).

Q: How much Ginkgo biloba should I take for Age-Related Cognitive Decline?

Studies have used various dosages. A commonly studied range is 120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Ginkgo biloba?

Reported side effects may include Headache, Gastrointestinal upset, Dizziness, Allergic skin reactions (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Ginkgo biloba and Age-Related Cognitive Decline?

We rate the evidence as Grade C (Some Evidence). This rating is based on 40 peer-reviewed studies with 8,000 total participants. The overall direction of effect is mixed.

The most studied herbal cognitive supplement. The large GEM trial (3,069 participants) found no evidence for dementia prevention in healthy elderly. However, EGb 761 standardized extract shows modest benefits in existing cognitive impairment.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dginkgo\u002Dbiloba\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Sonuç

Key Study Findings

Review

EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years?

Dose: None vs: placebo Outcome: cognitive assessment scores (MMSE, SKT, NPI) Etki: None None

Popülasyon: patients with mild-to-moderate Alzheimer disease or vascular dementia

Review

Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future.

Dose: None vs: None Outcome: None Etki: None None

Popülasyon: patients with vascular cognitive impairment and dementia

Review

The Use of Natural Products for Preventing Cognitive Decline/Providing Neuroprotection.

Dose: None vs: None Outcome: None Etki: None None

Popülasyon: Review of natural products for neuroprotection

Review

Can supplementation with antioxidants improve cognitive functions in patients with multiple sclerosis? A literature review.

Dose: None vs: None Outcome: Cognitive function in multiple sclerosis Etki: None None

Popülasyon: Multiple sclerosis patients (review)

Review

Nutritional strategies against dementia in rural populations.

Dose: None vs: None Outcome: None Etki: None None

Popülasyon: Rural populations with dementia risk

Cohort Study n=64 52 weeks Open-label

Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment.

Dose: 240 mg/day vs: Standard cognitive enhancers Outcome: Cognitive responder rate and AD conversion Etki: 100% vs 59.1% responders; 0% vs 13.6% AD conversio <0.001 (responders); 0.037 (AD

Popülasyon: Amyloid PET-positive MCI patients

Key Statistics

Çalışmalar

8000

Katılımcılar

↔

Mixed

Derece

Referenced Papers

EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years? Review

American journal of … None 1 atıf

Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future. Review

Neuropsychopharmacology : official … 2026 1 atıf

Inhibition of mitochondrial oxidative stress and apoptosis in the protection of Ginkgo biloba extract 50 against cognitive impairment. Other

Journal of ethnopharmacology 2025 5 atıf

Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment. Other

Frontiers in neurology 2025 4 atıf

Can supplementation with antioxidants improve cognitive functions in patients with multiple sclerosis? A literature review. Review

Annals of medicine … 2025 3 atıf

The Use of Natural Products for Preventing Cognitive Decline/Providing Neuroprotection. Review

Handbook of experimental … 2025 1 atıf

Nutritional strategies against dementia in rural populations. Review

Frontiers in nutrition 2025

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. Review

Degenerative neurological and … 2024 66 atıf

Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease. Review

Journal of Alzheimer's … 2024 12 atıf

Comprehensive Insights into Pathophysiology of Alzheimer's Disease: Herbal Approaches for Mitigating Neurodegeneration. Review

Current Alzheimer research 2024 10 atıf

Multicenter, Open-Label, Prospective Study Shows Safety and Therapeutic Benefits of a Defined Ginkgo Biloba Extract for Adults with Major Neurocognitive … Other

Dementia and geriatric … 2024 6 atıf

Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial. RCT

Medicine 2024 3 atıf

A mixture of extracts from natural ingredients reduces the neurotoxic polarization of microglia via modulating NF-κB/NF-E2-related factor 2 activation. Other

Food science & … 2024 3 atıf

Polyherbal and Multimodal Treatments: Kaempferol- and Quercetin-Rich Herbs Alleviate Symptoms of Alzheimer's Disease. Review

Biology 2023 37 atıf

A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress. RCT

Scientific reports 2023 30 atıf

A systematic review of the safety and efficacy on cognitive function of herbal and nutritional medicines in older adults with … Systematic Review

Systematic reviews 2023 10 atıf

Neuroprotective Herbs for the Management of Alzheimer's Disease. Review

Biomolecules 2021 161 atıf

The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. Review

Journal of clinical … 2021 38 atıf

Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®). Review

Pharmaceuticals (Basel, Switzerland) 2021 33 atıf

The Effect of Polyphenols on Working and Episodic Memory in Non-pathological and Pathological Aging: A Systematic Review and Meta-Analysis. Systematic Review

Frontiers in nutrition 2021 26 atıf

Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review. Systematic Review

Journal of alternative … 2021 13 atıf

Effectiveness and Safety Profile of Ginkgo biloba Standardized Extract (EGb761®) in Patients with Amnestic Mild Cognitive Impairment. Other

CNS & neurological … 2021 12 atıf

[Pharmacological prevention of cognitive decline and dementia]. Review

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2020 4 atıf

Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence. Review

Oxidative medicine and … 2019 102 atıf

Combining a high DHA multi-nutrient supplement with aerobic exercise: Protocol for a randomised controlled study assessing mobility and cognitive function … Other

Prostaglandins, leukotrienes, and … 2019 5 atıf

Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review. Systematic Review

Annals of internal … 2018 119 atıf

Nutritional prevention of cognitive decline and dementia. Review

Acta bio-medica : … 2018 103 atıf

Botanicals and phytochemicals active on cognitive decline: The clinical evidence. Review

Pharmacological research 2018 67 atıf

Forestalling the Epidemics of Parkinson's Disease Through Plant-Based Remedies. Review

Frontiers in nutrition 2018 18 atıf

Diabetes and Cognitive Decline in Older Adults: The Ginkgo Evaluation of Memory Study. RCT

The journals of … 2017 97 atıf

Memory Complaints and Cognitive Decline: Data from the GUIDAGE Study1. RCT

Journal of Alzheimer's … 2017 17 atıf

An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia. Review

Frontiers in aging … 2016 72 atıf

DHA Supplementation Alone or in Combination with Other Nutrients Does not Modulate Cerebral Hemodynamics or Cognitive Function in Healthy Older … RCT

Nutrients 2016 53 atıf

Inflammatory Biomarkers and Cognitive Decline: The Ginkgo Evaluation of Memory Study. RCT

Journal of the … 2016 16 atıf

Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition … Meta-Analysis

The American journal … 2015 204 atıf

Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis. Meta-Analysis

Climacteric : the … 2015 92 atıf

The use of Ginkgo biloba in healthy elderly. Other

Age (Dordrecht, Netherlands) 2014

Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients. Review

Clinical pharmacokinetics 2013 220 atıf

Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence. Review

CNS drugs 2013 138 atıf

Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study. Other

PloS one 2013 73 atıf

Ginkgo biloba extract EGb 761® in the context of current developments in the diagnosis and treatment of age-related cognitive decline … Review

International psychogeriatrics 2012 29 atıf

Treatment of Alzheimer disease. Other

American family physician 2011

Supplementing cognitive aging: a selective review of the effects of ginkgo biloba and a number of everyday nutritional substances. Review

Experimental aging research 2010 21 atıf

Ginkgo biloba and cognitive decline. Other

JAMA 2010 3 atıf

Normal cognitive decline or dementia? Other

The Practitioner 2010

Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. RCT

JAMA 2009 304 atıf

Ginkgo biloba for cognitive impairment and dementia. Meta-Analysis

The Cochrane database … 2009 299 atıf

Dementia prevention: methodological explanations for inconsistent results. Review

Epidemiologic reviews 2008 172 atıf

A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. RCT

Neurology 2008 147 atıf

Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine. Other

The Canadian veterinary … 2008

Herbal drug treatment. Review

Neuro endocrinology letters 2008

Ginkgo biloba for cognitive impairment and dementia. Meta-Analysis

The Cochrane database … 2007 375 atıf

Antioxidant strategies for Alzheimer's disease. Review

The Proceedings of … 2002 191 atıf

Ginkgo biloba for cognitive impairment and dementia. Meta-Analysis

The Cochrane database … 2002

A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Review

Alternative medicine review … 1999 112 atıf

Nutrients, age and cognitive function. Review

Current opinion in … 1998 30 atıf

Ginkgo biloba extract and cognitive decline. Other

British journal of … 1993 8 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:: 120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones

Üst sınır: 600 mg/day (doses above show no additional benefit)

Araştırmalarda İncelenen Dozajlar

Dozaj	Süre	Etki	N
None	--	Mixed	--
None	--	Mixed	--
None	--	Mixed	--
None	--	Mixed	--
None	--	Mixed	--
240 mg/day	52 weeks	Positive	64
None	--	Positive	--
None	--	Neutral	--

En iyi alım zamanı: With meals; may require 4-6 weeks for full effects

Safety & Side Effects

Bildirilen Yan Etkiler

⚠ Headache
⚠ Gastrointestinal upset
⚠ Dizziness
⚠ Allergic skin reactions (rare)
⚠ Increased bleeding risk

Bilinen Etkileşimler

● Anticoagulants and antiplatelet drugs (increased bleeding risk)
● Anticonvulsants (may reduce seizure threshold)
● SSRIs (serotonin syndrome risk, rare)
● CYP3A4 substrates (may affect drug metabolism)

Tolere edilebilir üst alım: 600 mg/day (doses above show no additional benefit)

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Ginkgo biloba help with Age-Related Cognitive Decline?

Based on 40 studies with 8,000 participants, there is limited but promising evidence that Ginkgo biloba may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).

How much Ginkgo biloba should I take for Age-Related Cognitive Decline?

Studies have used various dosages. A commonly studied range is 120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Ginkgo biloba?

Reported side effects may include Headache, Gastrointestinal upset, Dizziness, Allergic skin reactions (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Ginkgo biloba and Age-Related Cognitive Decline?

We rate the evidence as Grade C (Some Evidence). This rating is based on 40 peer-reviewed studies with 8,000 total participants. The overall direction of effect is mixed.

Related Evidence

Şu durum için diğer içerikler: Age-Related Cognitive Decline

Omega-3 Fatty Acids (DHA/EPA) A Phosphatidylserine B Bacopa monnieri B Vitamin B12 B Curcumin B Panax Ginseng C

Ginkgo biloba diğer sağlık durumları için

Cerebrovascular Health B

Hızlı Değerlendirme

Evidence Strength52%

Moderate confidence

Çalışma Dağılımı

RCT (8)Meta (5)Other (27)

Alternatifleri Karşılaştır

Bu durum için diğer bileşenlerin nasıl karşılaştırıldığını görün.Diğer içeriklerin bu sağlık durumu için nasıl karşılaştırıldığını görün.

Şu durum için tüm içerikleri görüntüle: Age-Related Cognitive Decline

Daha Fazla Bilgi

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.